COLO B — Coloplast A/S Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Coloplast A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18,544	19,426	22,579	24,500	27,030
Cost of Revenue
Gross Profit	12,612	13,313	15,529	16,328	18,269
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	12,690	13,271	16,140	17,729	19,710
Operating Profit	5,854	6,155	6,439	6,771	7,320
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,466	6,233	6,127	6,025	6,395
Provision for Income Taxes
Net Income After Taxes	4,197	4,825	4,706	4,783	5,052
Net Income Before Extraordinary Items
Net Income	4,197	4,825	4,706	4,783	5,052
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,197	4,825	4,706	4,783	5,052
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	19.7	23.4	23.8	22.5	22.3
Dividends per Share